Notch signaling: switching an oncogene to a tumor suppressor.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalHistone demethylase LSD1 controls the phenotypic plasticity of cancer cellsTherapies targeting cancer stem cells: Current trends and future challengesExpression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast CancerTargeted Therapy in Biliary Tract CancersThe role of aberrant proteolysis in lymphomagenesisThe Eighth Central European Conference "Chemistry towards Biology": SnapshotNovel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.Turn It Down a NotchVerification of microRNA expression in human endometrial adenocarcinoma.The potential of microRNAs in personalized medicine against cancers.Cyclin C is a haploinsufficient tumour suppressor.Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications.PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheresNotch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis.A cancer theory kerfuffle can lead to new lines of researchNotch signaling activation in pediatric low-grade astrocytomaPotential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABLLightening up a notch: Notch regulation of energy metabolism.Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors.Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.The Notch-mediated hyperplasia circuitry in Drosophila reveals a Src-JNK signaling axis.Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis.Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in mice.Notch as a Possible Cell Differentiation Factor in Pleomorphic Adenomas.The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.Drosophila as a model for the two myeloid blood cell systems in vertebrates.Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cellsc-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.The challenge of targeting notch in hematologic malignancies.Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Role of the ubiquitin proteasome system in hematologic malignancies.Pancreatic cancer stem cells.microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis.DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis.Notch4 promotes gastric cancer growth through activation of Wnt1/β-catenin signaling.Developing HSCs become Notch independent by the end of maturation in the AGM region.Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization.
P2860
Q26744536-EFAEF08C-676B-4BAA-ABB5-A523580C7EF5Q26745452-CBADBEBB-D1EA-4628-83FB-0149E2D28321Q26777880-8FB94E7D-6C62-49B9-AEB1-6E7E41362FB7Q26785389-3A55C769-D490-4B06-A382-9C19D00A45CFQ26798443-FEE1C702-9746-41C3-BE10-1D432AD8E5CEQ28084404-43B8CEC2-9CD4-4D77-9FBC-3AE0D1B7677DQ28817788-218C9BAD-6C61-4B34-B890-423C45DF7CF7Q30401533-C6E97CA0-E25C-46F1-B2FC-5A550E82BBDBQ33364683-3E5219D7-EABA-44EB-B3D0-721C2C621CA7Q33816414-F9243B70-F3BC-4EEC-AE78-1510A629B7E3Q34177547-ABEDE503-5878-4001-9AEA-3F1D8D637F7EQ34444847-7394808A-1FE7-4CFE-8096-DEAD303B31B1Q34494195-742BD109-C458-4435-A5CF-A302E397EFA2Q34765897-51C1125E-D6E4-4CFB-9BBF-2382D76CBC8FQ34898535-3E2F13B1-7EBE-430E-BD80-C8A4D3525C8EQ35078573-F6F7C84F-114D-4D07-BEBC-5C29B35530C5Q35170287-1C2DCA57-C2D8-494F-8788-60AF041097E5Q35596540-9EAF504B-184C-4195-BF95-7AEA58710489Q35606440-8C228B03-B87D-4B22-BD89-2FFC69FE4720Q35676920-D1AC7485-F88E-4527-989F-94473007E389Q35869326-FEEFDCB3-CADC-47E5-B955-C23B5AB17CCDQ35896180-D23A7306-68A8-4B70-9D88-9E2BC6BE97CBQ36070536-91CDF5CB-7CE8-4EBE-9232-3011DC8F34B0Q36137458-BA2E115D-F1D2-462A-8DC9-22B49863E0E5Q36189733-AEDD9FDA-F26C-494E-8B23-9C6D3B3C2D68Q36715896-5A37449C-D7BB-4139-A427-B7F6EEB9498CQ37235632-44EAC881-D679-484D-84F7-0FF4606C7C2DQ37615949-E1BED081-EE41-48BB-86A3-F0831999287AQ37718379-7E7AC18A-4517-4110-8611-0955F0BA9EE4Q38222770-E2E2F18E-E95A-4C0B-B66A-85B29AD1B547Q38289038-12409F0D-C7F2-4483-858D-16F076B192EAQ38289055-C70FF5F9-D6CE-47FB-AFDB-9F5DBC398DD2Q38516947-30F192F9-7793-405D-B6A0-A451BF40563DQ38668239-DED6F22F-E91E-443F-B066-0F6FF157B39BQ38717772-6162B5A9-80BB-4405-BCAC-CDF0B45B90A2Q38866748-BB3C249F-131C-4DA3-8EED-2782255543DFQ38928324-3BAF8EBA-6B55-4AF4-BA0F-D0B54865DE3BQ39597373-C2393643-3FAF-4849-A575-613E5F55904EQ39881866-4F5AEF49-324A-4973-8198-67A4BE6FACBDQ40217716-41A84C85-4DEF-4A3C-8B4F-2CB9F7C31DCD
P2860
Notch signaling: switching an oncogene to a tumor suppressor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Notch signaling: switching an oncogene to a tumor suppressor.
@en
Notch signaling: switching an oncogene to a tumor suppressor.
@nl
type
label
Notch signaling: switching an oncogene to a tumor suppressor.
@en
Notch signaling: switching an oncogene to a tumor suppressor.
@nl
prefLabel
Notch signaling: switching an oncogene to a tumor suppressor.
@en
Notch signaling: switching an oncogene to a tumor suppressor.
@nl
P2093
P2860
P1433
P1476
Notch signaling: switching an oncogene to a tumor suppressor
@en
P2093
A Thomas Look
Iannis Aifantis
P2860
P304
P356
10.1182/BLOOD-2013-08-355818
P407
P577
2014-03-07T00:00:00Z